4//SEC Filing
MCCRACKEN EDWARD R 4
Accession 0001182469-04-000002
CIK 0000889057other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:56 PM ET
Size
12.3 KB
Accession
0001182469-04-000002
Insider Transaction Report
Form 4
TULARIK INCTLRK
MCCRACKEN EDWARD R
Director
Transactions
- Disposition to Issuer
Common Stock
2004-08-13−70,512→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−10,000→ 0 totalExercise: $14.40Exp: 2012-04-17→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−8,000→ 0 totalExercise: $25.38Exp: 2010-04-26→ Common Stock (8,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 31,800 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F2]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 26, 2004, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $56.27 per share.
- [F3]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 24, 2005, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $46.41 per share.
- [F4]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 18 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 4,510 shares of Amgen common stock for $31.93 per share.
Documents
Issuer
TULARIK INC
CIK 0000889057
Entity typeother
Related Parties
1- filerCIK 0001182469
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:56 PM ET
- Size
- 12.3 KB